The Role of Bariatric Surgery in Gynecologic Oncology
Özet
Obesity is a major global health problem and a key modifiable risk factor for gynecologic malignancies, particularly endometrial cancer. Excess adipose tissue promotes carcinogenesis through hormonal dysregulation, chronic inflammation, insulin resistance, and adipokine imbalance, and increasing organ size may further expand the pool of susceptible target cells. Bariatric and metabolic surgery (MBS), mainly sleeve gastrectomy and Roux-en-Y gastric bypass (RYGB), provide durable weight loss, metabolic improvement, and substantial reductions in obesity-related cancer risk. Observational cohorts and meta-analyses consistently demonstrate lower incidence of endometrial, ovarian, breast and colorectal cancers, as well as reduced cancer-specific and all-cause mortality after MBS. Emerging data indicate regression of endometrial hyperplasia and early endometrial carcinoma in women undergoing bariatric surgery, and pilot trials suggest the feasibility of combined gynecologic and bariatric procedures in carefully selected patients. Current American Society For Metabolic and Bariatric Surgery(ASMBS)–International Federation For The Surgery and Obesity (IFSO) guidelines broaden indications to include patients with Body Mass Indeks (BMI) ≥35 kg/m² regardless of comorbidities and those with BMI 30–34.9 kg/m² with metabolic disease; however, major oncology guidelines have not yet incorporated MBS as a standard anticancer intervention. This chapter summarizes epidemiologic, pathophysiologic and clinical evidence, highlights perioperative Enahnced Recovery After Surgery (ERAS)-based management, and outlines key research priorities including fertility preservation, pharmacokinetics of systemic therapies, procedure-specific outcomes, and integrated cancer prevention strategies.
Referanslar
Webb, P.M. Obesity and gynecologic cancer etiology and survival. in American Society of Clinical Oncology Educational book. American Society of Clinical Oncology. Annual Meeting. 2013.
Agnew, H.J., S.J. Kitson, and E.J. Crosbie, Gynecological malignancies and obesity. Best Practice & Research Clinical Obstetrics & Gynaecology, 2023. 88: p. 102337.
Zhang, H.G.Y., et al., Organ size increases with obesity and correlates with cancer risk. arXiv preprint arXiv:2005.13112, 2020.
Ross, R.C., et al., The role of bariatric and metabolic surgery in the development, diagnosis, and treatment of endometrial cancer. Frontiers in surgery, 2022. 9: p. 943544.
Park, I.S., et al., Risk of female-specific cancers according to obesity and menopausal status in 2• 7 million Korean women: similar trends between Korean and Western women. The Lancet Regional Health–Western Pacific, 2021. 11.
Simancas-Racines, D., et al., Obesity and endometrial cancer: biological mechanisms, nutritional strategies, and clinical perspectives. Food and Agricultural Immunology, 2025. 36(1): p. 2510961.
Wilson, R.B., D. Lathigara, and D. Kaushal, Systematic review and meta-analysis of the impact of bariatric surgery on future cancer risk. International journal of molecular sciences, 2023. 24(7): p. 6192.
Bruno, D.S. and N.A. Berger, Impact of bariatric surgery on cancer risk reduction. Annals of Translational Medicine, 2020. 8(Suppl 1): p. S13.
Courcoulas, A.P., Bariatric Surgery and Cancer Risk. JAMA, 2022. 327(24): p. 2400-2402.
Mayo Clinic. Sleeve gastrectomy (vertical sleeve gastrectomy): About. Mayo Clinic; 2024. Available from: https://www.mayoclinic.org/tests-procedures/sleeve-gastrectomy/about/pac-20385183
Thaher, O., et al., Evaluation of the effect of sleeve gastrectomy versus Roux-en-Y gastric bypass in patients with morbid obesity: multicenter comparative study. Langenbeck's Archives of Surgery, 2024. 409(1): p. 156.
Au, C., et al., Surgical Strategies for the Management of Obesity. Methodist DeBakey Cardiovascular Journal, 2025. 21(2): p. 84.
Stahl, J.M. and S. Malhotra, Obesity surgery indications and contraindications, in StatPearls [Internet]. 2023, StatPearls Publishing.
Eisenberg, D., et al., 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery. Surgery for Obesity and Related Diseases, 2022. 18(12): p. 1345-1356.
Stenberg, E., et al., Guidelines for perioperative care in bariatric surgery: enhanced recovery after surgery (ERAS) society recommendations: a 2021 update. World journal of surgery, 2022. 46(4): p. 729-751.
Rudiman, R. and R.V. Hanafi, Perioperative Care for Bariatric Surgery. Diagnostics, 2024. 14(18): p. 2095.
De Camilli, A.R., et al., Perioperative considerations for cancer patients with obesity: A narrative review. Trends in Anaesthesia and Critical Care, 2022. 46: p. 33-41.
Schroeder, R., D.T. HARRISON, and S.L. McGRAW, Treatment of adult obesity with bariatric surgery. American family physician, 2016. 93(1): p. 31-37.
Rustgi, V.K., et al., Bariatric surgery reduces cancer risk in adults with nonalcoholic fatty liver disease and severe obesity. gastroenterology, 2021. 161(1): p. 171-184. e10.
Ward, K.K., et al., Bariatric surgery decreases the risk of uterine malignancy. Gynecologic oncology, 2014. 133(1): p. 63-66.
Anveden, Å., et al., Long-term incidence of female-specific cancer after bariatric surgery or usual care in the Swedish Obese Subjects Study. Gynecologic Oncology, 2017. 145(2): p. 224-229.
Aminian, A., et al., Association of bariatric surgery with cancer risk and mortality in adults with obesity. Jama, 2022. 327(24): p. 2423-2433.
Syn, N.L., et al., Association of metabolic–bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. The Lancet, 2021. 397(10287): p. 1830-1841.
Lin, J., et al., Effect of bariatric surgery on endometrial cancer regression as part of fertility sparing treatment. Cancer Reports, 2023. 6(9): p. e1857.
Perrone, A.M., et al., Synergizing health: combined gynecological and bariatric robotic surgery for endometrial cancer in obese women. International Journal of Gynecological Cancer, 2024. 34(6): p. 956-957.
Eisenberg, D., et al., 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. 2023, Springer.
Nelson, G., et al., Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: addressing implementation challenges-2023 update. Gynecologic oncology, 2023. 173: p. 58-67.
Nelson, G., et al., Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations—2019 update. International Journal of Gynecological Cancer, 2019. 29(4): p. 651-668.
Key, N.S., et al., Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update. Journal of Clinical Oncology, 2023. 41(16): p. 3063-3071.
Mechanick, J.I., et al., Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures–2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surgery for Obesity and Related Diseases, 2020. 16(2): p. 175-247.
Parrott, J., et al., American Society for Metabolic and Bariatric Surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients. Surgery for Obesity and Related Diseases, 2017. 13(5): p. 727-741.
Oaknin, A., et al., Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of oncology, 2022. 33(9): p. 860-877.
Mooney, S.S. and P. Sumithran, Does weight loss in women with obesity induce regression of endometrial hyperplasia? A systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2023. 288: p. 49-55.
Mezzapesa, F., et al., Combined robotic surgery for concomitant treatment of endometrial cancer and obesity. Surgical endoscopy, 2024. 38(11): p. 6691-6699.
Kingma, J.S., et al., Oral drug dosing following bariatric surgery: general concepts and specific dosing advice. British Journal of Clinical Pharmacology, 2021. 87(12): p. 4560-4576.
Mercado, A., et al., Effects of bariatric surgery on drug pharmacokinetics—Preclinical studies. Frontiers in Pharmacology, 2023. 14: p. 1133415.
MacKintosh, M.L., et al., The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk. International journal of cancer, 2019. 144(3): p. 641-650.
Kim, J., et al., Long-Term Cancer Outcomes Following Bariatric Surgery: A Comparative Analysis of Surgical Procedures. Cancers, 2024. 16(22): p. 3730.
Liu, Y.-N., et al., Bariatric surgery reduces colorectal cancer incidence in obese individuals: Systematic review and meta-analysis. World Journal of Gastrointestinal Surgery, 2023. 15(10): p. 2331.
